Triple-negative breast cancer (TNBC) is a highly concerning subtype of breast cancer that is characterized by the absence of key receptors, including the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (2). This evidence concerns the gene PGR and triple-negative breast carcinoma.